Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by saltajaon Mar 16, 2016 9:26pm

133 Views

Post# 24667712

RE:RE:RE:RE:RE:RE:Question

GoTogether,
I think the answer you are looking for is that the laser isn't directed at the cancer cells, instead the goal is to uniformly illuminate the inner surface of the bladder. Hence why they fill it up with water to make it as close to a balloon as possible. And hence why Jeff Cassidy's computer simulations model where to place the fibre optic based to get uniform illumination. They want no "hot spots" so they don't damange the bladder. The instensity is chosen so the 10:1 difference in concentration of PDC in cancer cells causes enough reactive O_2 to kill the cancer cell but not enough in the good cells to kill them.

That is my understanding.
Cheers.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?